SHANGHAI INSTITUTE OF MATERIA MEDICA; CHINESE ACADEMY OF SCIENCES
发明人:
申请号：
EP06752998.2
公开号：
EP1900721B1
申请日:
2006.06.21
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention provides a substituted cyclic compound of the following general formula I or II: its preparation process and its use as a glucagon-like peptide-1 receptor regulator for preventing or treating metalbolic disorders including, but not limited to, diabetes, insulin resistance and obesity, etc.
